Search Within

Anne S Reiner

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (11)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. GSK Faculty (26)
  2. Human Oncology and Pathogenesis Program (26)
  3. Tow Center for Developmental Oncology (TCDO) (20)
  4. Epidemiology and Biostatistics (19)
  5. Biostatistics Service (16)
  6. Department of Pathology and Laboratory Medicine (16)

More Groups

People
  1. Ingo Mellinghoff (20)
  2. Katherine Panageas (14)
  3. Elena Pentsova (10)
  4. Lisa De Angelis (10)
  5. Subhiksha Nandakumar (10)
  6. Thomas Kaley (10)

More People

Years
  1. 2024 (9)
  2. 2023 (4)
  3. 2022 (1)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Neuro-Oncology (8)
  2. Clinical Cancer Research (4)
  3. Journal of Clinical Oncology (4)
  4. Blood (3)
  5. Acta Neuropathologica (1)
  6. Acta Neuropathologica Communications (1)

More Publications

Publishers
  1. Oxford University Press (8)
  2. American Association for Cancer Research (5)
  3. American Society of Clinical Oncology (5)
  4. American Society of Hematology (3)
  5. Nature Publishing Group (2)
  6. BioMed Central Ltd. (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distinctive genomic alterations in testicular diffuse large B cell lymphoma
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Wang, L.; Intlekofer, A. M.; Copeland, A. R.; Jungbluth, A. A.; Reiner, A.; Pichardo, J. D.; Gallagher, M.; Bouvier, N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
    Journal Article

    Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Journal Article

    Omuro, A.; Chan, T. A.; Abrey, L. E.; Khasraw, M.; Reiner, A. S.; Kaley, T. J.; De Angelis, L. M.; Lassman, A. B.; Nolan, C. P.; Gavrilovic, I. T.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Meeting Abstract

    Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save